Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Safety, Randomized, Controlled, Open-label Study to Evaluate the Neuroprotective Effect of Hemodialysis of Plasma Glutamate and Proinflammatory Cytokines in the Acute Phase of Ischemic Stroke

NCT04297345 is registered in ClinicalTrials.gov with Fundación de Investigación Biomédica - Hospital Universitario de La Princesa as lead sponsor.

NCT NCT04297345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04297345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Safety, Randomized, Controlled, Open-label Study to Evaluate the Neuroprotective Effect of Hemodialysis of Plasma Glutamate and Proinflammatory Cytokines in the Acute Phase of Ischemic Stroke
Lead sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2021
Completion date
December 31, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular stroke